Manning & Napier Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Manning & Napier Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 24, 2019	SELL	$299.6 - $414.82 $46.3 Million - $64.1 Million	-154,597 Closed	0 $0
Q1 2019 Apr 10, 2019	SELL	$372.08 - $439.57 $19.5 Million - $23 Million	-52,274 Reduced 25.27%	154,597 $63.5 Million
Q4 2018 Jan 24, 2019	SELL	$335.82 - $403.04 $20.6 Million - $24.7 Million	-61,227 Reduced 22.84%	206,871 $77.3 Million
Q3 2018 Oct 10, 2018	SELL	$351.14 - $408.51 $87.2 Million - $101 Million	-248,240 Reduced 48.08%	268,098 $108 Million
Q2 2018 Jul 13, 2018	BUY	$284.6 - $344.99 $6.64 Million - $8.04 Million	23,315 Added 4.73%	516,338 $178 Million
Q1 2018 May 01, 2018	BUY	$315.82 - $393.78 $12.2 Million - $15.2 Million	38,688 Added 8.52%	493,023 $170 Million
Q4 2017 Feb 05, 2018	BUY	$358.63 - $469.95 $163 Million - $214 Million	454,335	454,335 $171 Million

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Manning & Napier Group, LLC with notifications on news.